000 -LEADER |
fixed length control field |
00759cam a22002051 4500 |
001 - CONTROL NUMBER |
control field |
3124888 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20140516150010.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
681210s1967 sz 000 0 eng |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Transcribing agency |
UG |
Modifying agency |
DLC |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS441 Wor |
Item number |
no. 364 |
110 2# - MAIN ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
World Health Organization. |
Subordinate unit |
Scientific Group on Principles for the Testing of Drugs for Teratogenicity. |
9 (RLIN) |
49322 |
245 10 - TITLE STATEMENT |
Title |
Principles for the testing of drugs for teratogenicity. |
Remainder of title |
Report of a WHO Scientific Group. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Geneva : |
Name of publisher, distributor, etc |
World Health Organization, |
Date of publication, distribution, etc |
1967. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
18 p. |
Dimensions |
24 cm. |
490 1# - SERIES STATEMENT |
Series statement |
World Health Organization. Technical report series, |
Volume number/sequential designation |
no. 364 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Teratogenic agents. |
9 (RLIN) |
49323 |
|
Topical term or geographic name as entry element |
Teratogenicity testing. |
9 (RLIN) |
49324 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Verified |
NK |